Lactate transport and signaling in the brain: Potential therapeutic targets and roles in body-brain interaction

Journal of Cerebral Blood Flow and Metabolism

Volumn 35, Issue 2, 2015, Pages 176-185

  Bergersen, Linda Hildegard ^a,b,c  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

blood brain barrier; energy metabolism; exercise; lactate; receptors

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 81; HYDROXYCARBOXYLIC ACID RECEPTOR 1; LACTIC ACID; MONOCARBOXYLATE TRANSPORTER; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG; CELL RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; GPR81 PROTEIN, HUMAN;

ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN; BRAIN INJURY; COGNITIVE DEFECT; ENERGY METABOLISM; EXERCISE; HUMAN; LACTATE BLOOD LEVEL; LIFESTYLE; MESIAL TEMPORAL LOBE EPILEPSY; NERVE CELL; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENE EXPRESSION REGULATION; GLYCOLYSIS; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ANIMALS; BRAIN; EXERCISE; GENE EXPRESSION REGULATION; GLYCOLYSIS; HUMANS; LACTIC ACID; MONOCARBOXYLIC ACID TRANSPORTERS; OXIDATION-REDUCTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84922337335     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2014.206     Document Type: Review

References (142)

1. Bergersen LH. Is lactate food for neurons? Comparison of monocarboxylate transporter subtypes in brain and muscle. Neuroscience 2007; 145: 11-19.
2. Halestrap AP. The SLC16 gene family - structure, role and regulation in health and disease. Mol Aspects Med 2013; 34: 337-349.
3. Bergersen LH, Gjedde A. Is lactate a volume transmitter of metabolic states of the brain? Front Neuroenergetics 2012; 4: 5.
4. Lauritzen KH, Morland C, Puchades M, Holm-Hansen S, Hagelin EM, Lauritzen F et al. Lactate receptor sites link neurotransmission, neurovascular coupling, and brain energy metabolism. Cereb Cortex 2013; 24: 2784-2795.
5. Brooks GA. Cell-cell and intracellular lactate shuttles. J Physiol 2009; 587: 5591-5600.
6. Smith D, Pernet A, Hallett WA, Bingham E, Marsden PK, Amiel SA et al. Lactate: a preferred fuel for human brain metabolism in vivo. J Cereb Blood Flow Metab 2003; 23: 658-664.
7. Rasmussen P, Nyberg N, Jaroszewski JW, Krogh-Madsen R, Secher NH, Quistorff B et al. Brain nonoxidative carbohydrate consumption is not explained by export of an unknown carbon source: evaluation of the arterial and jugular venous metabolome. J Cereb Blood Flow Metab 2010; 30: 1240-1246.
8. van Hall G. Lactate kinetics in human tissues at rest and during exercise. Acta Physiol (Oxf) 2010; 199: 499-508.
9. Sokoloff L. The brain as a chemical machine. Prog Brain Res 1992; 94: 19-33.
10. Dalsgaard MK. Fuelling cerebral activity in exercising man. J Cereb Blood Flow Metab 2006; 26: 731-750.
11. Dienel GA. Fueling and imaging brain activation. ASN Neuro 2012; 4.
12. Barros LF. Metabolic signaling by lactate in the brain. Trends Neurosci 2013; 36: 396-404.
13. Dhar-Chowdhury P, Malester B, Rajacic P, Coetzee WA. The regulation of ion channels and transporters by glycolytically derived ATP. Cell Mol Life Sci 2007; 64: 3069-3083.
14. Wilson MC, Meredith D, Bunnun C, Sessions RB, Halestrap AP. Studies on the DIDS-binding site of monocarboxylate transporter 1 suggest a homology model of the open conformation and a plausible translocation cycle. J Biol Chem 2009; 284: 20011-20021.
15. Ovens MJ, Davies AJ, Wilson MC, Murray CM, Halestrap AP. AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10. Biochem J 2010; 425: 523-530.
16. Halestrap AP, Price NT. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 1999; 343: 281-299.
17. Philp NJ, Yoon H, Grollman EF. Monocarboxylate transporter MCT1 is located in the apical membrane and MCT3 in the basal membrane of rat RPE. Am J Physiol 1998; 274: R1824-R1828.
18. Crosnier C, Bustamante LY, Bartholdson SJ, Bei AK, Theron M, Uchikawa M et al. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 2011; 480: 534-537.
19. Wilson MC, Kraus M, Marzban H, Sarna JR, Wang Y, Hawkes R et al. The neuroplastin adhesion molecules are accessory proteins that chaperone the monocarboxylate transporter MCT2 to the neuronal cell surface. PLoS ONE 2013; 8: e78654.
20. Castorino JJ, Deborde S, Deora A, Schreiner R, Gallagher-Colombo SM, Rodriguez-Boulan E et al. Basolateral sorting signals regulating tissue-specific polarity of heteromeric monocarboxylate transporters in epithelia. Traffic 2011; 12: 483-498.
21. Deora AA, Philp N, Hu J, Bok D, Rodriguez-Boulan E. Mechanisms regulating tissue-specific polarity of monocarboxylate transporters and their chaperone CD147 in kidney and retinal epithelia. Proc Natl Acad Sci USA 2005; 102: 16245-16250.
22. Dienel GA. Brain lactate metabolism: the discoveries and the controversies. J Cereb Blood Flow Metab 2012; 32: 1107-1138.
23. Bergersen L, Waerhaug O, Helm J, Thomas M, Laake P, Davies AJ et al. A novel postsynaptic density protein: the monocarboxylate transporter MCT2 is colocalized with delta-glutamate receptors in postsynaptic densities of parallel fiber-Purkinje cell synapses. Exp Brain Res 2001; 136: 523-534.
24. Bergersen LH, Magistretti PJ, Pellerin L. Selective postsynaptic co-localization of MCT2 with AMPA receptor GluR2/3 subunits at excitatory synapses exhibiting AMPA receptor trafficking. Cereb Cortex 2005; 15: 361-370.
25. Jóhannsson E, Lunde PK, Heddle C, Sjaastad I, Thomas MJ, Bergersen L et al. Upregulation of the cardiac monocarboxylate transporter MCT1 in a rat model of congestive heart failure. Circulation 2001; 104: 729-734.
26. Bergersen LH, Thomas M, Jóhannsson E, Waerhaug O, Halestrap A, Andersen K et al. Cross-reinnervation changes the expression patterns of the monocarboxylate transporters 1 and 4: An experimental study in slow and fast rat skeletal muscle. Neuroscience 2006; 138: 1105-1113.
27. Rosafio K, Pellerin L. Oxygen tension controls the expression of the monocarboxylate transporter MCT4 in cultured mouse cortical astrocytes via ahypoxiainducible factor-1-mediated transcriptional regulation. Glia 2014; 62: 477-490.
28. Brix B, Mesters JR, Pellerin L, Jöhren O. Endothelial cell-derived nitric oxide enhances aerobic glycolysis in astrocytes via HIF-1-mediated target gene activation. J Neurosci 2012; 32: 9727-9735.
29. Cheng C, Edin NF, Lauritzen KH, Aspmodal I, Christoffersen S, Jian L et al. Alterations of monocarboxylate transporter densities during hypoxia in brain and breast tumour cells. Cell Oncol (Dordr) 2012; 35: 217-227.
30. Viollet B, Athea Y, Mounier R, Guigas B, Zarrinpashneh E, Horman S et al. AMPK: Lessons from transgenic and knockout animals. Front Biosci (Landmark Ed) 2009; 14: 19-44.
31. Takimoto M, Takeyama M, Hamada T. Possible involvement of AMPK in acute exercise-induced expression of monocarboxylate transporters MCT1 and MCT4 mRNA in fast-twitch skeletal muscle. Metabolism 2013; 62: 1633-1640.
32. Chen SD, Yang DI, Lin TK, Shaw FZ, Liou CW, Chuang YC et al. Roles of oxidative stress, apoptosis, PGC-1 and mitochondrial biogenesis in cerebral ischemia. Int J Mol Sci 2011; 12: 7199-7215.
33. König B, Koch A, Giggel K, Dordschbal B, Eder K, Stangl GI et al. Monocarboxylate transporter (MCT)-1 is up-regulated by PPARalpha. Biochim Biophys Acta 2008; 1780: 899-904.
34. König B, Fischer S, Schlotte S, Wen G, Eder K, Stangl GI et al. Monocarboxylate transporter 1 and CD147 are up-regulated by natural and synthetic peroxisome proliferator-activated receptor alpha agonists in livers of rodents and pigs. Mol Nutr Food Res 2010; 54: 1248-1256.
35. Matsuyama S, Ohkura S, Iwata K, Uenoyama Y, Tsukamura H, Maeda K et al. Food deprivation induces monocarboxylate transporter 2 expression in the brainstem of female rat. J Reprod Dev 2009; 55: 256-261.
36. Robinet C, Pellerin L. Brain-derived neurotrophic factor enhances the expression of the monocarboxylate transporter 2 through translational activation in mouse cultured cortical neurons. J Cereb Blood Flow Metab 2010; 30: 286-298.
37. Robinet C, Pellerin L. Brain-derived neurotrophic factor enhances the hippocampal expression of key postsynaptic proteins in vivo including the monocarboxylate transporter MCT2. Neuroscience 2011; 192: 155-163.
38. Chenal J, Pellerin L. Noradrenaline enhances the expression of the neuronal monocarboxylate transporter MCT2 by translational activation via stimulation of PI3K/Akt and the mTOR/S6K pathway. J Neurochem 2007; 102: 389-397.
39. Chenal J, Pierre K, Pellerin L. Insulin and IGF-1 enhance the expression of the neuronal monocarboxylate transporter MCT2 by translational activation viastimulation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin pathway. Eur J Neurosci 2008; 27: 53-65.
40. Rafiki A, Boulland JL, Halestrap AP, Ottersen OP, Bergersen L. Highly differential expression of the monocarboxylate transporters MCT2 and MCT4 in the developing rat brain. Neuroscience 2003; 122: 677-688.
41. Tekkok SB, Brown AM, Westenbroek R, Pellerin L, Ransom BR. Transfer of glycogenderived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity. J Neurosci Res 2005; 81: 644-652.
42. Pellerin L, Pellegri G, Bittar PG, Charnay Y, Bouras C, Martin JL et al. Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci 1998; 20: 291-299.
43. Pellerin L, Magistretti PJ. Sweet sixteen for ANLS. J Cereb Blood Flow Metab 2012; 32: 1152-1166.
44. Brown AM, Tekkok SB, Ransom BR. Glycogen regulation and functional role in mouse white matter. J Physiol 2003; 549: 501-512.
45. Broer S, Broer A, Schneider HP, Stegen C, Halestrap AP, Deitmer JW et al. Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochem J 1999; 341: 529-535.
46. Gerhart DZ, Enerson BE, Zhdankina OY, Leino RL, Drewes LR. Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats. Am J Physiol 1997; 273: E207-E213.
47. Koehler-Stec EM, Simpson IA, Vannucci SJ, Landschulz KT, Landschulz WH. Monocarboxylate transporter expression in mouse brain. Am J Physiol 1998; 275: E516-E524.
48. Leino RL, Gerhart DZ, Drewes LR. Monocarboxylate transporter (MCT1) abundance in brains of suckling and adult rats: a quantitative electron microscopic immunogold study. Brain Res Dev Brain Res 1999; 113: 47-54.
49. Froberg MK, Gerhart DZ, Enerson BE, Manivel C, Guzman-Paz M, Seacotte N et al. Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues. NeuroReport 2001; 12: 761-765.
50. Lauritzen F, Eid T, Bergersen LH. Monocarboxylate transporters in temporal lobe epilepsy: roles of lactate and ketogenic diet. Brain Struct Funct 2013; doi:10.1007/ s00429-013-0672-x (e-pub ahead of print).
51. Dalsgaard MK, Quistorff B, Danielsen ER, Selmer C, Vogelsang T, Secher NH et al. A reduced cerebral metabolic ratio in exercise reflects metabolism and not accumulation of lactate within the human brain. J Physiol 2004; 554: 571-578.
52. Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 2012; 487: 443-448.
53. Rinholm JE, Hamilton NB, Kessaris N, Richardson WD, Bergersen LH, Attwell D et al. Regulation of oligodendrocyte development and myelination by glucose and lactate. J Neurosci 2011; 31: 538-548.
54. Grollman EF, Philp NJ, McPhie P, Ward RD, Sauer B. Determination of transport kinetics of chick MCT3 monocarboxylate transporter from retinal pigment epithelium by expression in genetically modified yeast. Biochemistry 2000; 39: 9351-9357.
55. Chiry O, Fishbein WN, Merezhinskaya N, Clarke S, Galuske R, Magistretti PJ et al. Distribution of the monocarboxylate transporter MCT2 in human cerebral cortex: an immunohistochemical study. Brain Res 2008; 1226: 61-69.
56. Cornford EM, Hyman S. Blood-brain barrier permeability to small and large molecules. Adv Drug Deliv Rev 1999; 36: 145-163.
57. Gordon GR, Choi HB, Rungta RL, Ellis-Davies GC, MacVicar BA. Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature 2008; 456: 745-749.
58. Bergersen LH, Lauritzen KH, Lauritzen F, Puchades M, Gjedde A. Lactate receptor locations link neurotransmission, neurovascular coupling, and brain energy metabolism. J Cereb Blood Flow Metab 2012; 32: S183 [9th International Symposium on Functional Neuroreceptor Mapping of the Living Brain (NRM), Baltimore, MD, USA, August 09-11, 2012].
59. Bozzo L, Puyal J, Chatton JY. Lactate modulates the activity of primary cortical neurons through a receptor-mediated pathway. PLoS ONE 2013; 8: e71721.
60. Tang F, Lane S, Korsak A, Paton JF, Gourine AV, Kasparov S et al. Lactate-mediated glia-neuronal signalling in the mammalian brain. Nat Commun 2014; 5: 3284.
61. Cai TQ, Ren N, Jin L, Cheng K, Kash S, Chen R et al. Role of GPR81 in lactate-mediated reduction of adipose lipolysis. Biochem Biophys Res Commun 2008; 377: 987-991.
62. Liu C, Wu J, Zhu J, Kuei C, Yu J, Shelton J et al. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. J Biol Chem 2009; 284: 2811-2822.
63. Kuei C, Yu J, Zhu J, Wu J, Zhang L, Shih A et al. Study of GPR81, the lactate receptor, from distant species identifies residues and motifs critical for GPR81 functions. Mol Pharmacol 2011; 80: 848-858.
64. Ahmed K, Tunaru S, Tang C, Müller M, Gille A, Sassmann A et al. An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81. Cell Metab 2010; 11: 311-319.
65. Offermanns S, Colletti SL, Lovenberg TW, Semple G, Wise A, IJzerman AP et al. International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and classification of hydroxy-carboxylic acid receptors (GPR81, GPR109A, and GPR109B). Pharmacol Rev 2011; 63: 269-290.
66. Offermanns S. Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors. Annu Rev Pharmacol Toxicol 2014; 54: 407-434.
67. Liu C, Kuei C, Zhu J, Yu J, Zhang L, Shih A et al. 3,5-Dihydroxybenzoic acid, a specific agonist for hydroxycarboxylic acid 1, inhibits lipolysis in adipocytes. J Pharmacol Exp Ther 2012; 341: 794-801.
68. Reiter E, Ahn S, Shukla AK, Lefkowitz RJ. Molecular mechanism of arrestinbiased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol 2012; 52: 179-197.
69. Pierre K, Pellerin L, Debernardi R, Riederer BM, Magistretti PJ. Cell-specific localization of monocarboxylate transporters, MCT1 and MCT2, in the adult mouse brain revealed by double immunohistochemical labeling and confocal microscopy. Neuroscience 2000; 100: 617-627.
70. Malenka RC. Synaptic plasticity and AMPA receptor trafficking. Ann NY Acad Sci 2003; 1003: 1-11.
71. Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, Magistretti PJ et al. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 2011; 144: 810-823.
72. Attwell D, Gibb A. Neuroenergetics and the kinetic design of excitatory synapses. Nat Rev Neurosci 2005; 6: 841-849.
73. Peters A, Palay SL, Webster H. The fine structure of the nervous system3rd edOxford University Press: Oxford, 1991.
74. Caesar K, Hashemi P, Douhou A, Bonvento G, Boutelle MG, Walls AB et al. Glutamate receptor-dependent increments in lactate, glucose and oxygen metabolism evoked in rat cerebellum in vivo. J Physiol 2008; 586: 1337-1349.
75. Simpson IA, Carruthers A, Vannucci SJ. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab 2007; 27: 1-26.
76. DiNuzzo M, Mangia S, Maraviglia B, Giove F. Changes in glucose uptake rather than lactate shuttle take center stage in subserving neuroenergetics: evidence from mathematical modeling. J Cereb Blood Flow Metab 2010; 30: 586-602.
77. DiNuzzo M, Mangia S, Maraviglia B, Giove F. Glycogenolysis in astrocytes supports blood-borne glucose channeling not glycogen-derived lactate shuttling to neurons: evidence from mathematical modeling. J Cereb Blood Flow Metab 2010; 30: 1895-1904.
78. Nagase M, Takahashi Y, Watabe AM, Kubo Y, Kato F. On-site energy supply at synapses through monocarboxylate transporters maintains excitatory synaptic transmission. J Neurosci 2014; 34: 2605-2617.
79. Traynelis SF, Cull-Candy SG. Pharmacological properties and H+ sensitivity of excitatory amino acid receptor channels in rat cerebellar granule neurones. J Physiol 1991; 433: 727-763.
80. Mott DD, Washburn MS, Zhang S, Dingledine RJ. Subunit-dependent modulation of kainate receptors by extracellular protons and polyamines. J Neurosci 2003; 23: 1179-1188.
81. Pedersen TH, Nielsen OB, Lamb GD, Stephenson DG. Intracellular acidosis enhances the excitability of working muscle. Science 2004; 305: 1144-1147.
82. Aghajanian GK, Bloom FE. The formation of synaptic junctions in developing rat brain: a quantitative electron microscopic study. Brain Res 1967; 6: 716-727.
83. Sanchez-Abarca LI, Tabernero A, Medina JM. Oligodendrocytes use lactate as a source of energy and as a precursor of lipids. Glia 2001; 36: 321-329.
84. Nehlig A, Pereira de Vasconcelos A. Glucose and ketone body utilization by the brain of neonatal rats. Prog Neurobiol 1993; 40: 163-221.
85. Wu M, Hernandez M, Shen S, Sabo JK, Kelkar D, Wang J et al. Differential modulation of the oligodendrocyte transcriptome by sonic hedgehog and bone morphogenetic protein 4 via opposing effects on histone acetylation. J Neurosci 2012; 32: 6651-6664.
86. Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke 1996; 27: 1641-1646.
87. Karadottir R, Cavelier P, Bergersen LH, Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005; 438: 1162-1166.
88. Salter MG, Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005; 438: 1167-1171.
89. Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, Woulfe J et al. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 2006; 439: 988-992.
90. Manning SM, Talos DM, Zhou C, Selip DB, Park HK, Park CJ et al. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci 2008; 28: 6670-6678.
91. Ouardouz M, Coderre E, Basak A, Chen A, Zamponi GW, Hameed S et al. Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors. Ann Neurol 2009; 65: 151-159.
92. Ouardouz M, Coderre E, Zamponi GW, Hameed S, Yin X, Trapp BD et al. Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors. Ann Neurol 2009; 65: 160-166.
93. Rinholm JE, Bergersen LH. The wrap that feeds neurons. Nature 2012; 487: 435-436.
94. Kinney HC, Karthigasan J, Borenshteyn NI, Flax JD, Kirschner DA. Myelination in the developing human brain: biochemical correlates. Neurochem Res 1994; 19: 983-996.
95. Funfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 2012; 485: 517-521.
96. Nave KA. Myelination and the trophic support of long axons. Nat Rev Neurosci 2010; 11: 275-283.
97. Agnati LF, Guidolin D, Guescini M, Genedani S, Fuxe K. Understanding wiring and volume transmission. Brain Res Rev 2010; 64: 137-159.
98. Cerdán S, Rodrigues TB, Sierra A, Benito M, Fonseca LL, Fonseca CP et al. The redox switch/redox coupling hypothesis. Neurochem Int 2006; 48: 523-530.
99. Ramírez BG, Rodrigues TB, Violante IR, Cruz F, Fonseca LL, Ballesteros P et al. Kinetic properties of the redox switch/redox coupling mechanism as determined in primary cultures of cortical neurons and astrocytes from rat brain. J Neurosci Res 2007; 85: 3244-3253.
100. Gambini J, Gomez-Cabrera MC, Borras C, Valles SL, Lopez-Grueso R, Martinez-Bello VE et al. Free [NADH]/[NAD(+)] regulates sirtuin expression. Arch Biochem Biophys 2011; 512: 24-29.
101. Yang J, Ruchti E, Petit JM, Jourdain P, Grenningloh G, Allaman I et al. Lactate promotes plasticity gene expression by potentiating NMDA signaling in neurons. Proc Natl Acad Sci USA 2014; 111: 12228-12233.
102. Cureton EL, Kwan RO, Dozier KC, Sadjadi J, Pal JD, Victorino GP et al. A different view of lactate in trauma patients: protecting the injured brain. J Surg Res 2010; 159: 468-473.
103. Ros J, Pecinska N, Alessandri B, Landolt H, Fillenz M. Lactate reduces glutamateinduced neurotoxicity in rat cortex. J Neurosci Res 2001; 66: 790-794.
104. Bouzat P, Sala N, Suys T, Zerlauth JB, Marques-Vidal P, Feihl F et al. Cerebral metabolic effects of exogenous lactate supplementation on the injured human brain. Intensive Care Med 2014; 40: 412-421.
105. Vespa P, Bergsneider M, Hattori N, Wu HM, Huang SC, Martin NA et al. Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab 2005; 25: 763-774.
106. Hoque R, Farooq A, Ghani A, Gorelick F, Mehal WZ. Lactate reduces liver and pancreatic injury in Toll-like receptor-and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity. Gastroenterology 2014; 146: 1763-1774.
107. Wang M, Gamo NJ, Yang Y, Jin LE, Wang XJ, Laubach M et al. Neuronal basis of age-related working memory decline. Nature 2011; 476: 210-213.
108. Martínez M, Hernández AI, Hernanz A. Increased cAMP immunostaining in cerebral vessels in Alzheimer's disease. Brain Res 2001; 922: 148-152.
109. Canepa E, Domenicotti C, Marengo B, Passalacqua M, Marinari UM, Pronzato MA et al. Cyclic adenosine monophosphate as an endogenous modulator of the amyloid precursor protein metabolism. IUBMB Life 2013; 65: 127-133.
110. Wang M, Ramos BP, Paspalas CD, Shu Y, Simen A, Duque A et al. Alpha2Aadrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell 2007; 129: 397-410.
111. Arnsten AF. Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia. Int J Dev Neurosci 2011; 29: 215-223.
112. Avery MC, Dutt N, Krichmar JL. A large-scale neural network model of the influence of neuromodulatory levels on working memory and behavior. Front Comput Neurosci 2013; 7: 133.
113. O'Donnell J, Zeppenfeld D, McConnell E, Pena S, Nedergaard M. Norepinephrine: a neuromodulator that boosts the function of multiple cell types to optimize CNS performance. Neurochem Res 2012; 37: 2496-2512.
114. Coco M, Caggia S, Musumeci G, Perciavalle V, Graziano AC, Pannuzzo G et al. Sodium L-lactate differently affects brain-derived neurothrophic factor, inducible nitric oxide synthase, and heat shock protein 70 kDa production in human astrocytes and SH-SY5Y cultures. J Neurosci Res 2013; 91: 313-320.
115. Voss MW, Erickson KI, Prakash RS, Chaddock L, Kim JS, Alves H et al. Neurobiological markers of exercise-related brain plasticity in older adults. Brain Behav Immun 2013; 28: 90-99.
116. Religa P, Cao R, Religa D, Xue Y, Bogdanovic N, Westaway D et al. VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival. Sci Rep 2013; 3: 2053.
117. Cao L, Jiao X, Zuzga DS, Liu Y, Fong DM, Young D et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet 2004; 36: 827-835.
118. Bekinschtein P, Kent BA, Oomen CA, Clemenson GD, Gage FH, Saksida LM et al. BDNF in the dentate gyrus is required for consolidation of 'pattern-separated' memories. Cell Rep 2013; 5: 759-768.
119. Farmer J, Zhao X, van Praag H, Wodtke K, Gage FH, Christie BR et al. Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo. Neuroscience 2004; 124: 71-79.
120. Ding Q, Ying Z, Gómez-Pinilla F. Exercise influences hippocampal plasticity by modulating brain-derived neurotrophic factor processing. Neuroscience 2011; 192: 773-780.
121. de Lanerolle NC, Kim JH, Williamson A, Spencer SS, Zaveri HP, Eid T et al. A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories. Epilepsia 2003; 44: 677-687.
122. Liu B, Niu L, Shen MZ, Gao L, Wang C, Li J et al. Decreased astroglial monocarboxylate transporter 4 expression in temporal lobe epilepsy. Mol Neurobiol 2014; 50: 327-338.
123. van Hall G, Strømstad M, Rasmussen P, Jans O, Zaar M, Gam C et al. Blood lactate is an important energy source for the human brain. J Cereb Blood Flow Metab 2009; 29: 1121-1129.
124. Mueller AL, Dunwiddie TV. Anticonvulsant and proconvulsant actions of alphaand beta-noradrenergic agonists on epileptiform activity in rat hippocampus in vitro. Epilepsia 1983; 24: 57-64.
125. Draoui N, Schicke O, Fernandes A, Drozak X, Nahra F, Dumont A et al. Synthesis and pharmacological evaluation of carboxycoumarins as a new antitumor treatment targeting lactate transport in cancer cells. Bioorg Med Chem 2013; 21: 7107-7117.
126. Parks SK, Chiche J, Pouysségur J. Disrupting proton dynamics and energy metabolism for cancer therapy. Nat Rev Cancer 2013; 13: 611-623.
127. Rasmussen P, Brassard P, Adser H, Pedersen MV, Leick L, Hart E et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol 2009; 94: 1062-1069.
128. Foster PP, Rosenblatt KP, Kuljiš RO. Exercise-induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer's disease. Front Neurol 2011; 2: 28.
129. Zschucke E, Gaudlitz K, Ströhle A. Exercise and physical activity in mental disorders: clinical and experimental evidence. J Prev Med Public Health 2013; 46: S12-S21.
130. Whiteman AS, Young DE, He X, Chen TC, Wagenaar RC, Stern CE et al. Interaction between serum BDNF and aerobic fitness predicts recognition memory in healthy young adults. Behav Brain Res 2014; 259: 302-312.
131. Adlard PA, Engesser-Cesar C, Cotman CW. Mild stress facilitates learning and exercise improves retention in aged mice. Exp Gerontol 2011; 46: 53-59.
132. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 2011; 108: 3017-3022.
133. Komulainen P, Pedersen M, Hänninen T, Bruunsgaard H, Lakka TA, Kivipelto M et al. BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study. Neurobiol Learn Mem 2008; 90: 596-603.
134. Seifert T, Brassard P, Wissenberg M, Rasmussen P, Nordby P, Stallknecht B et al. Endurance training enhances BDNF release from the human brain. Am J Physiol Regul Integr Comp Physiol 2010; 298: R372-R377.
135. Coelho FG, Gobbi S, Andreatto CA, Corazza DI, Pedroso RV, Santos-Galduróz RF et al. Physical exercise modulates peripheral levels of brain-derived neurotrophic factor (BDNF): a systematic review of experimental studies in the elderly. Arch Gerontol Geriatr 2013; 56: 10-15.
136. Lanz TA, Bove SE, Pilsmaker CD, Mariga A, Drummond EM, Cadelina GW et al. Robust changes in expression of brain-derived neurotrophic factor (BDNF) mRNA and protein across the brain do not translate to detectable changes in BDNF levels in CSF or plasma. Biomarkers 2012; 17: 524-531.
137. Kandel ER. The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB. Mol Brain 2012; 5: 14.
138. Kida S. A functional role for CREB as a positive regulator of memory formation and LTP. Exp Neurobiol 2012; 21: 136-140.
139. Jeong S, Yoon M. Swimming's prevention of ovariectomy-induced obesity through activation of skeletal-muscle PPAR? Int J Sport Nutr Exerc Metab 2012; 22: 1-10.
140. Roy A, Jana M, Corbett GT, Ramaswamy S, Kordower JH, Gonzalez FJ et al. Regulation of cyclic AMP response element binding and hippocampal plasticityrelated genes by peroxisome proliferator-activated receptor ? Cell Rep 2013; 4: 724-737.
141. Russell AP, Foletta VC, Snow RJ, Wadley GD. Skeletal muscle mitochondria: a major player in exercise, health and disease. Biochim Biophys Acta 2014; 1840: 1276-1284.
142. Wrann CD, White JP, Salogiannnis J, Laznik-Bogoslavski D, Wu J, Ma D et al. Exercise induces hippocampal BDNF through a PGC-1/FNDC5 pathway. Cell Metab 2013; 18: 649-659.